Approvals/TGA/SPRAVATO esketamine (as hydrochloride) 28 mg per 2 actuations nasal spray solution

Approved

STANDARD

SPRAVATO esketamine (as hydrochloride) 28 mg per 2 actuations nasal spray solution

Janssen-Cilag Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: bc96b65b43e4a524
Product Name: SPRAVATO esketamine (as hydrochloride) 28 mg per 2 actuations nasal spray solution
Artg Id: 311827
Artg Name: SPRAVATO esketamine (as hydrochloride) 28 mg per 2 actuations nasal spray solution
Sponsor: Janssen-Cilag Pty Ltd
Company Detail Path: /organization/janssen-cilag-pty-ltd
Artg Date: 2021-03-09
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/effe1927676a80364ae20240fb6f475b.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/16b3cf744f282c206fa3bfe08dd3bc45.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

bc96b65b43e4a524

Type

Standard